NO960376L - Fremgangsmåte for krystallisering av iopamidol - Google Patents

Fremgangsmåte for krystallisering av iopamidol

Info

Publication number
NO960376L
NO960376L NO960376A NO960376A NO960376L NO 960376 L NO960376 L NO 960376L NO 960376 A NO960376 A NO 960376A NO 960376 A NO960376 A NO 960376A NO 960376 L NO960376 L NO 960376L
Authority
NO
Norway
Prior art keywords
iopamidol
crystallization
Prior art date
Application number
NO960376A
Other languages
English (en)
Other versions
NO304226B1 (no
NO960376D0 (no
Inventor
Marco Villa
Maurizio Paiocchi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI931720A external-priority patent/IT1257001B/it
Priority claimed from IT000760 external-priority patent/IT1269339B/it
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NO960376L publication Critical patent/NO960376L/no
Publication of NO960376D0 publication Critical patent/NO960376D0/no
Publication of NO304226B1 publication Critical patent/NO304226B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO960376A 1993-07-30 1996-01-29 FremgangsmÕte for krystallisering av iopamidol, samt anvendelse av butanoler ved krystalliseringen NO304226B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI931720A IT1257001B (it) 1993-07-30 1993-07-30 Processo per la cristalizzazione dello iopamidolo
IT000760 IT1269339B (it) 1994-04-20 1994-04-20 Processo per la cristallizzazione dello iopamidolo
PCT/EP1994/002415 WO1995004031A1 (en) 1993-07-30 1994-07-22 Process for the crystallization of iopamidol

Publications (3)

Publication Number Publication Date
NO960376L true NO960376L (no) 1996-01-29
NO960376D0 NO960376D0 (no) 1996-01-29
NO304226B1 NO304226B1 (no) 1998-11-16

Family

ID=26331032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960376A NO304226B1 (no) 1993-07-30 1996-01-29 FremgangsmÕte for krystallisering av iopamidol, samt anvendelse av butanoler ved krystalliseringen

Country Status (29)

Country Link
US (3) US5571941A (no)
JP (1) JP3299045B2 (no)
KR (1) KR100355211B1 (no)
CN (1) CN1035940C (no)
AT (1) AT404832B (no)
AU (1) AU690138B2 (no)
BE (1) BE1008403A4 (no)
CA (1) CA2128942C (no)
CH (1) CH686783A5 (no)
CZ (1) CZ289300B6 (no)
DE (1) DE4426818A1 (no)
DK (1) DK172074B1 (no)
ES (1) ES2102312B1 (no)
FI (1) FI960400L (no)
FR (1) FR2708601B1 (no)
GB (1) GB2280436B (no)
GR (1) GR940100366A (no)
HU (1) HU217023B (no)
IE (1) IE80675B1 (no)
IL (1) IL110391A (no)
NL (1) NL194272C (no)
NO (1) NO304226B1 (no)
NZ (1) NZ271632A (no)
PT (1) PT101554B (no)
RU (1) RU2135462C1 (no)
SE (1) SE9402595L (no)
SI (1) SI9420046B (no)
WO (1) WO1995004031A1 (no)
ZA (1) ZA945472B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110391A (en) 1993-07-30 1998-12-06 Zambon Spa Process for the crystallization of iopamidol
US6310243B1 (en) * 1994-09-23 2001-10-30 Nycomed Imaging As Iodinated x-ray contrast media
PT101720A (pt) * 1995-06-08 1997-01-31 Hovione Sociedade Quimica S A Processo para a purificacao e cristalizacao de iopamidol
EP0842141A1 (en) * 1995-07-04 1998-05-20 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY A process for preparing iopamidol by using a c1-c5 monoalkylether of a c2-c10 alkylen-glycol
KR100270411B1 (ko) * 1995-09-08 2000-11-01 네니드 토모브-그리소고노 (s)-n,n'-비스[2-히드록시-1-(히드록시메틸)에틸-5-[(2-히드록시-1-옥소프로필)아미노]-2,4,6-트리요오도-1,3-벤젠디카복사미드의물로부터의결정화방법
PT101919B (pt) * 1996-09-30 2000-01-31 Hovione Sociedade Quimica Sa Um processo para a purificacao de tohexol
JP4080545B2 (ja) * 1997-02-11 2008-04-23 ブラッコ・インテルナツイオナル・ベーヴェー （ｓ）−ｎ，ｎ′−ビス［２−ヒドロキシ−１−（ヒドロキシメチル）エチル］−５−［（２−ヒドロキシ−１−オキソプロピル）アミノ］−２，４，６−トリヨード−１，３−ベンゼンジカルボキシアミドを直鎖状または分岐状の（ｃ５〜ｃ６）アルコールまたはそれらの混合物から結晶化させる方法
GB9720969D0 (en) 1997-10-02 1997-12-03 Nycomed Imaging As Process
KR20000031642A (ko) * 1998-11-09 2000-06-05 강재헌 이오파미돌의 결정화 방법
US6265610B1 (en) 1999-01-12 2001-07-24 The University Of North Carolina At Chapel Hill Contrast media for angiography
US6803485B2 (en) 1999-02-26 2004-10-12 Bracco Imaging S.P.A. Process for the preparation of iopamidol
IT1319671B1 (it) 2000-12-01 2003-10-23 Bracco Spa Processo per la preparazione di (s)-n,n'-bis(2-idrossi-1-(idrossimetil)etil)-5-((2-idrossi-1-ossopropil)ammino)
NO20043305D0 (no) * 2004-08-09 2004-08-09 Amersham Health As Preparation of lodixanol
DE102005059191B4 (de) * 2005-12-05 2008-02-07 Bayer Schering Pharma Ag Verfahren zur Rückgewinnung von für pharmazeutische Zwecke geeignetem Iopromid aus Mutterlaugen
KR100976097B1 (ko) * 2008-12-05 2010-08-16 주식회사 대웅제약 이오프로마이드의 ｚ 이성체를 선택적으로 결정화하는 방법
AU2010232556A1 (en) * 2009-04-02 2011-11-03 Allergan, Inc. Prostaglandin E receptor antagonists
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
DE102012104679A1 (de) 2011-05-30 2012-12-06 Westfälische Wilhelms-Universität Münster Biotechnologische konversion von glycerin zu 2-amino-1,3-propandiol (serinol) in rekombinanten escherichia coli
CN104854080B (zh) 2012-12-19 2018-07-03 通用电气医疗集团股份有限公司 X-射线造影剂的纯化
KR102128423B1 (ko) * 2018-09-17 2020-07-01 (주)유케이케미팜 조영제 이오메프롤의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608189A5 (no) * 1974-12-13 1978-12-29 Savac Ag
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
IT1193211B (it) * 1979-08-09 1988-06-15 Bracco Ind Chimica Spa Derivati dell'acido 2,4,6-triiodo-isoftalico,metodo per la loro preparazione e mezzi di contrasto che li contengono
DE3150916A1 (de) * 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel"
US5204086A (en) * 1982-10-01 1993-04-20 Nycomed Imaging As X-ray contrast agent
CA1327600C (en) * 1987-05-22 1994-03-08 Ernest Felder Process for the preparation of 5-acylamino-2,4,6- triiodo-or tribromo-benzoic acid derivatives and corresponding novel 5-acylamino-2,4,6-triiodo or tribromo-benzoic acid derivatives obtained by said process
IT1248741B (it) * 1991-02-26 1995-01-26 Bracco Spa Processo di concentrazione e di purificazione di composti organici
IL110391A (en) 1993-07-30 1998-12-06 Zambon Spa Process for the crystallization of iopamidol

Also Published As

Publication number Publication date
JPH07145125A (ja) 1995-06-06
ZA945472B (en) 1995-03-03
CZ289300B6 (cs) 2001-12-12
IE80675B1 (en) 1998-11-18
CA2128942C (en) 2003-07-15
FR2708601A1 (fr) 1995-02-10
AU690138B2 (en) 1998-04-23
BE1008403A4 (fr) 1996-05-07
USRE36433E (en) 1999-12-07
CN1128020A (zh) 1996-07-31
ES2102312B1 (es) 1998-04-01
AU7532194A (en) 1995-02-28
JP3299045B2 (ja) 2002-07-08
FI960400A0 (fi) 1996-01-29
IL110391A0 (en) 1994-10-21
FI960400A7 (fi) 1996-01-29
ATA150594A (de) 1998-07-15
FI960400L (fi) 1996-01-29
CH686783A5 (it) 1996-06-28
PT101554B (pt) 2000-01-31
DE4426818A1 (de) 1995-02-02
NO304226B1 (no) 1998-11-16
KR100355211B1 (ko) 2003-04-10
WO1995004031A1 (en) 1995-02-09
NL9401229A (nl) 1995-02-16
RU2135462C1 (ru) 1999-08-27
KR960703842A (ko) 1996-08-31
DK89294A (da) 1995-01-31
SE9402595L (sv) 1995-01-31
SI9420046B (sl) 2003-10-31
PT101554A (pt) 1995-05-04
US6506938B1 (en) 2003-01-14
GR940100366A (en) 1996-03-31
NZ271632A (en) 1997-07-27
NO960376D0 (no) 1996-01-29
CA2128942A1 (en) 1995-01-31
GB2280436B (en) 1997-08-13
NL194272B (nl) 2001-07-02
SE9402595D0 (sv) 1994-07-29
GB2280436A (en) 1995-02-01
DK172074B1 (da) 1997-10-13
HUP9774567A2 (en) 1997-01-28
SI9420046A (en) 1996-10-31
IL110391A (en) 1998-12-06
HU217023B (hu) 1999-11-29
GB9414912D0 (en) 1994-09-14
CN1035940C (zh) 1997-09-24
ES2102312A1 (es) 1997-07-16
CZ183194A3 (en) 1995-02-15
US5571941A (en) 1996-11-05
NL194272C (nl) 2001-11-05
IE940609A1 (en) 1995-02-08
FR2708601B1 (fr) 1995-12-08
HU9600191D0 (en) 1996-11-28
AT404832B (de) 1999-03-25

Similar Documents

Publication Publication Date Title
NO960376L (no) Fremgangsmåte for krystallisering av iopamidol
NO934304D0 (no) Fremgangsm}te for behandling av fluoralumosilikatglass
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO970153L (no) Fremgangsmåte for syntese av substituerte sulfoksider
DE69620107D1 (de) Kristallisationsverfahren
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO306620B1 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
NO953443D0 (no) Fremgangsmåte for behandling av fast avfall
NO943652D0 (no) Fremgangsmåte for fremstilling av 3-aminopyridiner fra 3-nitropyridiner
NO940171L (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
NO944238D0 (no) Fremgangsmåte for fremstilling av hydroxyalkancarboxylsyreamider
FI953617L (fi) Menetelmä substituoitujen 4-hydroksikumariinien valmistamiseksi
FI943660A7 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
BR9205373A (pt) Processo para cristalizacao de ester alfa-i-aspartil-i-fenilalanina metilico
FI955282L (fi) Menetelmä NG-monoalkyyli-L-arginiinin ja vastaavien yhdisteiden valmistamiseksi
KR960700250A (ko) 비코자마이신 벤조에이트의 제조 방법(Process for Producing Bicozamycin Benzoate)
ITMI940760A0 (it) Processo per la cristallizzazione dello iopamidolo
IS4086A (is) Aðferð við framleiðslu efnasambanda
NO178346C (no) Framgangsmåte for framstilling av ferrosilisium
HU9402423D0 (en) Process for the manufacture of phenoxyphenoxyalkyl derivatives
FI932887L (fi) Parannettu menetelmä 4-nitro-3-trifluorometyylianiliinin valmistamiseksi
ITMI931720A0 (it) Processo per la cristalizzazione dello iopamidolo
FI933652A7 (fi) Menetelmä 1-substituoimattomien 3-aminopyrrolien valmistamiseksi
ITMI912137A0 (it) Processo per alfa-monoalchilazione di arilacetonitrili

Legal Events

Date Code Title Description
MK1K Patent expired